RMH - CAR-T Treatment
A Contract Award Notice
by THE ROYAL MARSDEN NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract ()
- Duration
- not specified
- Value
- £380K
- Sector
- MISCELLANEOUS
- Published
- 24 Oct 2025
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
Geochart for 1 buyers and 1 suppliers
1 buyer
- Royal Marsden NHS Trust London
1 supplier
- Unnamed None
Description
CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team (MDT). The product should meet strict NHS England standards for cryogenic storage and handling and RMH has such credentials.
Award Detail
| 1 | Unnamed (None)
|
CPV Codes
- None found
Legal Justification
this particular field of treatment is very patient specific
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-05d335
- FTS 068116-2025